Get started
Author

Lucy F. Chen

Observed name: Lucy F Chen
OpenAlex ID: A5043972299
New Strategies in Head and Neck Cancer: Understanding Resistance to Epidermal Growth Factor Receptor Inhibitors
2010 · Lucy F. Chen, Ezra E.W. Cohen, et al. · Clinical Cancer Research · 118
Magnetic resonance imaging identifies multifocal and multicentric disease in breast cancer patients who are eligible for partial breast irradiation
2008 · Hania A. Al‐Hallaq, Loren K. Mell, et al. · Cancer · 61
PDF
Phase III study of androgen deprivation therapy (ADT) with enzalutamide (ENZA) or placebo (PBO) in metastatic hormone-sensitive prostate cancer (mHSPC): The ARCHES trial.
2019 · Andrew J. Armstrong, Russell Zelig Szmulewitz, et al. · Journal of Clinical Oncology · 30
Racial differences in head and neck squamous cell carcinomas among non-Hispanic black and white males identified through the National Cancer Database (1998–2012)
2016 · Caryn E. Peterson, Shaveta Khosla, et al. · Journal of Cancer Research and Clinical Oncology · 30
Evolving use of radiotherapy and radiosurgery in the treatment of pituitary adenomas
2006 · Kiran Devisetty, Lucy F Chen, et al. · Expert Review of Anticancer Therapy · 5
ARCHES: Efficacy of androgen deprivation therapy (ADT) with enzalutamide (ENZA) or placebo (PBO) in metastatic hormone-sensitive prostate cancer (mHSPC).
2019 · Andrew J. Armstrong, Russell Zelig Szmulewitz, et al. · Journal of Clinical Oncology · 4
Efficacy and safety of fruquintinib in patients with metastatic colorectal cancer according to prior treatment sequence in the refractory setting: Results from FRESCO and FRESCO-2.
2024 · Tanios S. Bekaii-Saab, Arvind Dasari, et al. · Journal of Clinical Oncology · 2
PDF
Advances in Brain Metastases Presented at the American Society of Clinical Oncology 2016 Annual Meeting: Part II
2016 · Lucy F Chen, Jyoti D Patel, et al. · Future Oncology · 2
PDF
Advances in Brain Metastases Presented at the American Society of Clinical Oncology 2016 Annual Meeting: Part I
2016 · Lucy F Chen, Jyoti D Patel, et al. · Future Oncology · 2
PDF
Overall survival with fruquintinib versus placebo after adjusting for subsequent anticancer therapy in patients with refractory metastatic colorectal cancer in the FRESCO-2 study.
2025 · Sara Lonardi, Arvind Dasari, et al. · Journal of Clinical Oncology
PDF
Overall survival with fruquintinib versus placebo after adjusting for subsequent anticancer therapy in patients with refractory metastatic colorectal cancer in the FRESCO-2 study.
2025 · Sara Lonardi, Arvind Dasari, et al. · Journal of Clinical Oncology
Quality-adjusted time without symptoms of disease or toxicity (Q-TWiST) analysis of fruquintinib + best supportive care (BSC) compared with placebo + BSC in metastatic colorectal cancer (mCRC): Results from the FRESCO-2 trial.
2024 · Sebastian Stintzing, Josep Tabernero, et al. · Journal of Clinical Oncology
PDF
Chemotherapy for Squamous Cell Carcinoma of the Lip
2013 · Lucy F. Chen, Gowri Ramadas · Springer eBooks
Works count: 13
Citation count: 254
H-index: 5
I10-index: 4
Year
Topic
Type